Although the focus of this TSPO PET study was assessing early anti-inflammatory effects of minocycline treatment, other studies performed a follow up of rats after SE to the chronic disease phase: Bertoglio et al. conclude from their findings that TSPO PET might serve as a biomarker for early prediction of epileptic seizure frequency [56], and a further study identified TSPO PET as a predictor of treatment response to anti-seizure drugs [57]. This evidence concerns the gene TSPO and Seizure.